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Abstract
Objectives: The aim of this study was to identify factors that predict the failure of a ‘no drain’ policy in
laparoscopic hepatectomy.
Methods: Surgical outcomes in 342 consecutive patients undergoing laparoscopic hepatectomy were
reviewed. Drains were placed only for the following predefined criteria: (i) intraoperative bile leak;
(ii) bilioenteric anastomosis, and (iii) increased risk for postoperative bleeding (‘no drain’ policy). Factors
leading to need for postoperative drainage or reoperation were evaluated.
Results: Drains were placed in 44 patients (drainage group). Postoperatively, additional procedures were
required in five (11.4%) patients in the drainage group and in 18 (6.0%) patients in the no-drainage group.
Multivariate analysis suggested that blood loss of >400 ml [odds ratio (OR) 4.50, 95% confidence interval
(CI) 1.41–14.2; P = 0.010] and preoperative chemotherapy (OR = 2.24, 95% CI 0.82–6.48; P = 0.120) may
increase the risk for need for postoperative procedures when intraoperative prophylactic drainage is not
used.
Conclusions: Prophylactic drainage during liver resection should be considered not only in the presence
of uncontrollable bile leak or concern for postoperative bleeding risk, but also in patients who have
undergone neoadjuvant chemotherapy and those in whom intraoperative blood loss is >400 ml. Other-
wise, a ‘no drain’ policy is safe and would enhance the advantages of minimally invasive liver surgery.
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Introduction
The use of prophylactic abdominal drainage in liver resection is a
controversial. Traditionally, prophylactic drainage has been advo-
cated for the prevention of postoperative fluid collections, the
detection and drainage of bile leak, and the identification of
bleeding,1 especially in complicated liver resection.2,3 In addition,
in the largest Asian series of liver resection without mortality,
routine abdominal drainage was employed.4–6 However, the extent
to which the placement of prophylactic drainage contributes to
satisfactory surgical outcomes remains unclear.
By contrast, since the late 1990s most Western series have
advised against the routine placement of drains in elective liver
surgery.7–12 Negative effects of routine abdominal drainage on
the incidence of postoperative infection10 and development of
ascites7,10 have been demonstrated in open liver resection.
Recently, a pooled meta-analysis comparing routine abdominal
drainage (n = 234) with no abdominal drainage (n = 231) in
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elective liver surgery found no difference between the two groups
with respect to mortality, intra-abdominal collections requiring
reoperation, infected intra-abdominal collections, wound infec-
tion, ascitic leak or hospital stay.13 To the present authors’ knowl-
edge, however, there have been no reports focusing on the role of
prophylactic abdominal drainage in the setting of minimally inva-
sive liver surgery, in which surgeons may be more reluctant to use
prophylactic drains than in open hepatectomy. The present study
evaluated surgical outcomes of laparoscopic hepatectomy (LH)
carried out using a restrictive drain placement strategy in 342
consecutive patients with the aim of identifying clinical factors
that predict failure of the ‘no drain’ policy.
Materials and methods
Patients
Subjects included 342 consecutive patients who underwent
laparoscopic hepatic resection at the Institute Mutualiste
Montsouris, Paris, France between 1995 and 2010. During the
study period, 136 patients underwent open hepatic surgery and
were excluded from this analysis. The laparoscopic approach
was offered to patients without contraindications specific to
pneumoperitoneum. Predefined exclusion criteria included
closed-angle glaucoma, intracranial hypertension, diffuse bullous
emphysema, and contraindications specific to surgical techniques
including a need for complex vascular and/or biliary reconstruc-
tion. Previous open abdominal surgery was considered to be a
relative contraindication for LH because of the complexity of
dissection.
Preoperative evaluation and care
Resectability was assessed preoperatively by ultrasonography,
computed tomography and/or magnetic resonance imaging.
Portal vein embolization or ligation was indicated if the estimated
remnant liver volume was <25–30% of total liver volume in
patients without cirrhosis or <40% in patients with cirrhosis.
Neoadjuvant chemotherapy [infusional fluorouracil, leucovorin
and oxaliplatin (FOLFOX) and/or infusional fluorouracil,
leucovorin and irinotecan (FOLFIRI)] was administered in
patients with colorectal liver metastasis if they had synchronous
metastasis, more than three resectable metastases or initially
unresectable metastases. In patients with synchronous metastases,
hepatic and colorectal resection was considered during the same
operation.
Surgical techniques
The specific technical details of LH have been described
previously.14–16 Briefly, patients were placed in the low lithotomy
position, with the legs spread apart and bent at the knees (French
position). Usually, five or six trocars were placed in the right upper
quadrant of the abdomen, using one 12-mm port for the laparo-
scope and another for intraoperative ultrasonography. For LH of
Couinaud segments VII andVIII, two trocars were placed through
the diaphragm in addition to three trocars placed in the right
upper quadrant of the abdomen (the lateral approach).16 Intra-
abdominal pressure was maintained at 10–12 mmHg.14
Prior to parenchymal dissection, an umbilical tape was passed
around the hepatoduodenal ligament for inflow occlusion, when
needed. Liver anatomy and dissection planes were mapped using
intraoperative ultrasonography with a flexible laparoscopic probe
(BK Medical APS, Herlev, Denmark). The liver parenchyma
was then dissected using bipolar forceps (MicroFrance CEV134;
Medtronic, Inc., Minneapolis, MN, USA) and ultrasonic shears,
usually a SonoSurg (Olympus Co., Tokyo, Japan) or Harmonic
Scalpel (Ethicon Endo-Surgery, Inc., Cincinnati, OH, USA).
During parenchymal dissection, central venous pressure was kept
low and monitored visually by confirming inferior vena cava fluc-
tuation and heartbeat and ventilator data.
‘No drain’ policy
After parenchymal dissection was completed, any areas of obvious
bile leakage were addressed with absorbable sutures or clips. Bile
leak testing was performed after major hepatectomy by injecting
air through a transcystic catheter and evaluating visually for the
presence of bubbles. Radiographic cholangiography was not rou-
tinely used for this purpose. Criteria indicating the need to deviate
from the ‘no drain’ policy were predefined. Closed suction drains
were used in the following circumstances: (i) intraoperative bile
leak from liver parenchyma or bile ducts; (ii) bilioenteric anasto-
mosis, and (iii) increased risk for postoperative bleeding. Fibrin
glue or a carrier-bound fibrin sealant (Tachosil™; Nycomed
Austria GmbH, Linz, Austria) was applied on the raw surface for
bleeding control in complex hepatic resections.
Postoperatively, patients were followed clinically and liver func-
tion tests were assessed. Ultrasonography and other examinations
were ordered as indicated. Drains were removed usually on post-
operative day (PoD) 3 if the amount and visual inspection of the
drainage was not concerning. Fluid collections in the abdominal
cavity were drained percutaneously under ultrasound guidance or
by reoperation when the fluid collection was symptomatic
(abdominal pain, fever of >38 °C and/or white blood cell count of
>100 000/μl and rising).
Statistical analysis
Patients’ background characteristics and surgery-related factors
were analysed retrospectively to identify possible risk factors con-
tributing to the occurrence of postoperative complications that
required additional procedures. Categorical data and continuous
data [expressed as median (range)] were compared using Fisher’s
exact test and theWilcoxon rank sum test, respectively.Differences
of statistical significance were indicated by a P-value of <0.05. In a
multiple logistic regression analysis, a P-value of <0.20 was set as
the cut-off value for elimination. The results were expressed as
adjusted odds ratios (ORs) with 95% confidence intervals (CIs),
and P-values were calculated using the likelihood ratio test. Cal-
culations were performed using jmp Version 9.0.0 (SAS Institute,
Inc., Cary, NC, USA).
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Results
Demographic data
The study population included 204 men and 138 women, with a
median age of 61 years (range: 18–88 years). Laparoscopic hepa-
tectomy was indicated for malignancy in 273 patients (secondary
liver malignancy, n = 228; primary liver malignancy, n = 36; hilar
bile duct cancer, n = 8; gallbladder cancer, n = 1) and for benign
lesions in the remaining 69 patients (liver cell adenoma, n = 16;
focal nodular hyperplasia, n = 15; liver cysts, n = 9; hepatic
hamartoma, n = 6; other, n = 23). A total of 24 (7.0%) patients had
chronic hepatitis or liver cirrhosis and, of the 147 patients who
had undergone neoadjuvant chemotherapy, 38 (25.8%) had
steatohepatitis and/or hepatic sinusoidal obstruction based on
pathological diagnosis.
The median operating time required for hepatectomy was
195 min (range: 15–515 min). Median blood loss amounted to
150 ml (range: 5–1500 ml). Red blood cell transfusions were
required in 26 patients. Conversion to open surgery was required
in 18 patients as a result of haemorrhage (n = 8), severe adhesions
(n = 4), localization of the tumour (n = 3), necessity for complex
bile duct reconstruction (n = 2), and opening of the thoracic
cavity (n = 1).
The presence or absence of abdominal drainage and
postoperative course
Figure 1 summarizes the postoperative course in the 342 patients
with respect to the placement of abdominal drainage at the time of
surgery. Abdominal drainage was used in 44 patients (drainage
group). The remaining 298 patients did not undergo drain place-
ment at the time of surgery and thus were considered as the
‘no-drainage group’ in this study. The proportions of patients
submitted to major hepatectomy (hemi-hepatectomy or extended
hepatectomy) were 77.3% (n = 34) in the drainage group and
27.8% (n = 83) in the no-drainage group.
Postoperatively, additional procedures (percutaneous drainage
and/or haemostasis/lavage by reoperation) were required in five
(11.4%) patients in the drainage group and in 18 (6.0%) patients
in the no-drainage group. Overall, 280 of 342 subjects did not
require either prophylactic drainage or postoperative procedures.
The incidence of postoperative bile leak was 15.9% (n = 7) in the
drainage group and 2.0% (n = 6) in the no-drainage group.
Major postoperative complications (grade III or higher accord-
ing to Clavien–Dindo classification17) occurred in 11 (25.0%)
patients in the drainage group and in 24 (8.1%) patients in the
no-drainage group (P = 0.002). These included symptomatic fluid
collection with or without evidence of bacterial infection (drain-
age group, n = 1; no-drainage group, n = 9), bile leak (drainage
group, n = 7; no-drainage group, n = 6), bleeding (drainage group,
n = 0; no-drainage group, n = 3), liver insufficiency (drainage
group, n = 1; no-drainage group, n = 2), sepsis (drainage group,
n = 1; no-drainage group, n = 1), cerebral infarction (drainage
group, n = 1; no-drainage group, n = 1), stenosis of the bile duct
(drainage group, n = 0; no-drainage group, n = 1), and mesenteric
artery embolism (drainage group, n = 0; no-drainage group, n =
1). Of the 342 subjects, three (0.9%) patients in the no-drainage
group died. One of these exsanguinated from the stump of the
portal vein as a result of the migration of vascular clips on PoD 6,
after hospital discharge. The other patients experienced, respec-
tively, cerebral infarction on PoD 9, and hepatic and renal insuf-
ficiency on PoD 43 following severe late-onset cholestasis without
intrahepatic biliary dilatation or abnormal hepatic blood flow,
probably as a result of chemotherapy-associated steatohepatitis
diagnosed by pathological examination. The median postopera-
tive hospital stay was 7 days (range: 2–68 days).
Risk factors for additional postoperative procedures
Background characteristics and surgery-related factors were com-
pared among 298 patients in the no-drainage group, including the
18 patients in whom additional postoperative procedures were
required, and the remaining 280 patients who did not require
intervention (Table 1). Five potential risk factors for which
univariate analysis showed P-values of <0.20 [i.e. preoperative
chemotherapy, location and extent of resection, amount of blood
Laparoscopic hepatectomy
(n = 342)
Prophylactic abdominal drainage
Postoperative drainage reoperation
(n = 44, 13%)
(n = 5, 11%)
Reasons:
• Risk of bile leak (27)
• Risk of rebleeding (12)
• Biliary anastomosis (4)
• Lymphorrhea (1)
Reasons:
• Bile leak (3)
• Symptomatic
  fluid collection (2)
(n = 18, 6%)
Reasons:
• Symptomatic
  fluid collection (8)
• Bile leak (6)
• Bleeding (3)
• Mesenteric artery
  thrombosis (1)
(n = 39, 89%)
• Asymptomatic
  fluid collection (1)
• Inflammatory
  reactiona (2)
(n = 280, 94%)
• Asymptomatic
  fluid collection (5)
• Inflammatory
  reactiona (13)
YES
(n = 298, 87%)
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YES NO YES NO
Figure 1 Postoperative course in 342 consecutive patients submit-
ted to laparoscopic hepatectomy who did (n = 44, drainage group)
and did not (n = 298, no-drainage group) receive prophylactic drain-
age. Postoperatively, additional procedures (percutaneous drainage
and/or haemostasis/lavage by reoperation) were required in five
patients in the drainage group and 18 patients in the no-drainage
group. aInflammatory reaction (fever of >38 °C and white blood cell
count of >100 000/μl and rising) not associated with abdominal fluid
collection
496 HPB
HPB 2014, 16, 494–499 © 2013 International Hepato-Pancreato-Biliary Association
loss (>400 ml or <400 ml), operation time (>300 min or
<300 min)], were included in multivariate analysis. Blood loss of
>400 ml (n = 47; OR = 4.50, 95% CI 1.41–14.2; P = 0.010) and
preoperative chemotherapy (n = 118; OR = 2.24, 95% CI 0.82–
6.48; P = 0.120) were estimated to increase the risk for need
for additional procedures postoperatively when prophylactic
abdominal drainage was not used at the time of surgery (Table 2).
In patients with intraoperative blood loss of >400 ml (n = 7),
the leading causes of additional postoperative procedures were
bleeding (n = 3) and symptomatic fluid collection (n = 3), whereas
symptomatic fluid collection (n = 6) was the most prevalent indi-
cation for postoperative procedures among patients submitted to
preoperative chemotherapy (n = 11).
Discussion
In this series of LH utilizing a ‘no drain’ policy, 87.1% of all treated
patients did not undergo prophylactic drain placement (the
no-drainage group); the remaining 12.9% of patients were
drained during surgery because of bile leakage (7.9%), concern
for the adequacy of haemostasis (3.5%), biliary anastomosis
(1.2%) and lymphorrhea (0.3%). Overall, 94.0% of patients in the
no-drainage group did not require postoperative drainage pro-
cedures (percutaneous drainage and/or reoperation) to treat com-
plications specific to the liver resection. The percentages of
patients who required postoperative procedures did not differ
significantly between the drainage group (11.4%) and the
no-drainage group (6.0%). Surgical outcomes and the proportion
of patients who required postoperative procedures in this series
are comparable with those established in previous randomized
controlled trials of drain placement in open surgery,7,8,10–12 as well
as in a large case series1 describing the routine use of prophylactic
drains (Table 3). Although this is a retrospective cohort study, the
current results support the validity of a ‘no drain’ policy [i.e. the
restrictive use of prophylactic drainage only if there is a perceived
clinically significant risk for postoperative bile leak (intraoperative
bile leakage or biliary anastomosis/suture) or concern for the
adequacy of haemostasis prior to abdominal closure].
Although a recent systematic review indicates a paucity of evi-
dence to support routine drainage after uncomplicated liver resec-
tion,13 the definition of ‘uncomplicated liver resection’ remains
vague. In previous studies, biliary anastomosis has been regarded
as the major clinical factor indicating the need for prophylactic
drainage (Table 3).7–12 In the present study, prophylactic drains
were placed in patients with intraoperative bile leak or biliary
anastomosis or suturing. As a result, the incidence of postopera-
tive bile leakage was higher in the drainage group (15.9%) than in
the no-drainage group (2.0%), which suggests that the clinical
stratification of patients according to risk for postoperative bile
leak is effective. By contrast, 6.0% of patients in the no-drainage
Table 1 Risk factors for postoperative drainage procedures to treat complications associated with liver resection in 298 patients submitted
to laparoscopic hepatectomy without prophylactic abdominal drain placement (no-drainage group)
Postoperative interventions P-value
Yes No
Age, years, median (range) 63 (32–79) 62 (18–89) 0.571
Hepatitis or cirrhosis, present/absent, n 1/17 19/261 >0.999
Preoperative chemotherapy, yes/no, n 11/7 107/173 0.080
History of previous hepatectomy, yes/no, n 1/17 40/240 0.484
Simultaneous colorectal resection, yes/no, n 3/15 28/252 0.415
Extent of hepatectomy, hemiliver or extended/lessa, n 8/10 75/205 0.112
Number of hepatectomy, multiple/single, n 2/16 49/231 0.748
Location of resection, superior or dorsal regionb/other, n 13/5 123/157 0.027
Distribution of resection, bilobar/unilobar, n 4/14 35/245 0.271
Operation time, min, median (range) 210 (120–420) 180 (15–515) 0.037
Amount of blood loss, ml, median (range) 400 (100–1300) 100 (5–1500) 0.001
aIncluding central bisectorectomy (segments IV, V and VIII, n = 1), anatomic bisegmentectomy (n = 14), segmentectomy (n = 35), subsegmentectomy
(n = 10), left lobectomy (segments II and III, n = 24), and non-anatomic partial resection (n = 121).
bLiver resections associated with segments I, VII, VIII and/or the superior region of segment IV (subsegment IVa).
Table 2 Multivariate analysis to identify risk factors for postoperative
intervention in patients submitted to laparoscopic hepatectomy
Variable OR 95% CI P-value
Amount of blood loss, >400 ml 4.50 1.41–14.2 0.010
Preoperative chemotherapy, yes 2.24 0.82–6.48 0.120
Location of resection, superior or
dorsal regiona
2.05 0.51–8.10 0.295
Operation time, >300 min 1.38 0.36–4.81 0.626
Extent of hepatectomy, hemi-
hepatectomy or more
1.33 0.35–4.90 0.667
aLiver resections associated with Couinaud segments I, VII, VIII and/or
the superior region of segment IV (subsegment IVa).
OR, odds ratio; 95% CI, 95% confidence interval.
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group required postoperative drainage procedures, indicating that
additional criteria for placing prophylactic drains may be required
in order to capture all patients who should receive a drain at the
time of surgery.
In this study,multivariate analysis revealed that operative blood
loss of >400 ml independently increased the risk for requiring
postoperative additional procedures. Excessive intraoperative
blood loss is a strong indicator of postoperative bleeding risk, and
may also trigger postoperative ascitic fluid accumulation through
water and sodium retention following a decrease in effective arte-
rial blood volume18 and blood transfusion. This is demonstrated
herein, as well as in a previous study.19 Based on confidence inter-
vals in the multivariate analysis, preoperative chemotherapy was
also estimated to be a risk factor for need for postoperative pro-
cedures. In patients who underwent preoperative chemotherapy,
the leading cause of need for postoperative intervention was fluid
collection with or without evidence of bacterial infection. This
may be related to chemotherapy-associated liver injury.20
Although the mechanism by which this arises remains unclear,
previous studies suggest an association with sinusoidal obstruc-
tion syndrome21 and steatosis or steatohepatitis22–24 as a result of
preoperative chemotherapy, leading to an increased incidence of
postoperative complications including bile leak and ascitic fluid
retention, which may require drainage.
In the present series, all of the three postoperative deaths
occurred in the no-drainage group. However, two of these
patients died of cerebral infarction and postoperative liver insuf-
ficiency, respectively, which were not directly related to the pres-
ence or absence of prophylactic drains. The remaining patient
died of exsanguination related to the failure of vascular clips at
the stump of the right portal vein branch, just after hospital dis-
charge on PoD 6. As abdominal drains are typically removed
when effluent is minimal and does not indicate concern for bile
leak or bleeding, normally on PoD 2 or 3, this postoperative
death could not have been avoided even if a prophylactic drain
had been placed.
Table 3 Surgical outcomes after liver resection in patients with prophylactic drain placement and in those without intraoperative drainage
Arm (n) Bile
leak,
%
Percutaneous
drainage, %
Reoperation,
%
Mortality,
%
Exclusion criteria for
no-drainage group
HCC,
%
Hemi- or
extended
hepatectomy,
%
Belghiti
et al.7a
Drain (42) 4.8% 35.7% 2.4% 2.4% Biliary enteric anastomosis,
gastrointestinal
procedure, total hepatic
vascular exclusion, ex
situ perfused liver,
devitalized hepatic
stump, bile duct injury
26% 30%
No drain (39) 5.1% 15.8% 2.5% 2.6%
Fong
et al.8a
Drain (60) 5.0% 8.3% 1.6% 3.3% Biliary enteric anastomosis,
thoracoabdominal
incision, preoperative
biliary stent
14% 73%
No drain (60) 5.0% 18.3% 0% 3.3%
Fuster
et al.11a
Drain (20) 0% 0% 0% 0% Major liver resection or
tumour ≥ 5 cm
100% 0%
No drain (20) 0% 10.0% 5.0% 0%
Liu
et al.10a
Drain (52) 3.8% 3.8% 5.8% 5.8% Biliary enteric anastomosis 96% 60%
No drain (52) 0% 0% 1.9% 1.9%
Sun
et al.12a
Drain (60) 0% 5.0% 2.0% 0% Biliary anastomosis,
operation on other organ,
infection
72% 41%
No drain (60) 0% 2.0% 0% 2.0%
Burt
et al.9b
Drain (184) – 26.1% – 7.1% Thoracotomy, uncontrollable
bile leak, biliary
anastomosis, abdominal
infection
9% 58%
No drain (981) – 10.5% – 2.0%
Kyoden
et al.1c
Drain (1269) 8.7% 2.0% 1.6% 0.07% (Routine drainage) 71% 13%
Present
studyd
Drain (44) 16.0% 9.1% 4.6% 0% Uncontrollable bile leak,
biliary anastomosis,
concern for postoperative
bleeding risk
10% 34%
No drain (298) 2.0% 5.4% 2.4% 1.0%
aRandomized controlled trial.
bRetrospective case series of open liver resection with ‘no drain’ policy.
cRetrospective case series of open liver resection with routine prophylactic drainage.
dRetrospective case series of laparoscopic liver resection with ‘no drain’ policy.
HCC, hepatocellular carcinoma.
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In line with the available literature on restricted drain
placement,7–12 the current study suggests that indications for the
placement of prophylactic drains in liver resection may be similar
in both laparoscopic and open surgery (Table 3). Nevertheless, the
present study is limited by the fact that only a small proportion of
the study population had chronic hepatitis or cirrhosis (7.0%)
because the incidence of postoperative complications is poten-
tially higher in these patients than in those with normal liver
function.6 With regard to liver cirrhosis, the use of prophylactic
drains with appropriate fluid and diuretic therapy may be an
effective strategy by which to avoid the occurrence of massive
postoperative ascites, which may lead to liver failure.19
In conclusion, the present data support the claim that there is
no need for routine drainage in hepatic resection unless there is a
clinical risk for bile leak (indicated by bile leakage at the comple-
tion of the operation or requirement for a biliary anastomosis or
suturing) or concern for the adequacy of haemostasis. More spe-
cifically, the data suggest that the ‘no drain’ policy can be safely
applied in LH and will enhance the advantages of minimally inva-
sive surgery, unless intraoperative blood loss is >400 ml and the
patient has undergone neoadjuvant chemotherapy.
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